Normal view MARC view ISBD view

Development of Metal Nanoparticle Catalysis toward Drug Discovery. [electronic resource]

By:

Arisawa, Mitsuhiro

Producer: 20190819Description: 733-771 p. digitalISSN:

1347-5223

Subject(s):

Online resources:

Available from publisher's website

In: Chemical & pharmaceutical bulletin vol. 67

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

1 An interview with Ralph W. deVere White. Interview by John Fitzpatrick.
by deVere White, Ralph W
2 Transurethral resection of superficial bladder cancer using 5-aminolevulinic acid: are there any long-term benefits?
by Devere White, Ralph W
3 Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
by Vinall, Ruth L
4 Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
by Nesslinger, Nancy J
5 The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.
by deVere White, Ralph W
6 Cancerous miRNAs and their regulation.
by Shi, Xu-Bao
7 Canine prostatic intraepithelial neoplasia: is the comparative model relevant?
by Madewell, Bruce R
8 Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians?
by Chamie, Karim
9 Influence of short polyglutamine tracts and p160 coactivators on the transactivation of the androgen receptor.
by Shi, Xu-Bao
10 Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma.
by Hellenthal, Nicholas J
11 The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1.
by Liao, Yi-Chun
12 Is bladder biopsy necessary at three or six months post BCG therapy?
by Highshaw, Ralph A
13 MicroRNAs and their potential for translation in prostate cancer.
by DeVere White, Ralph W
14 The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapy.
by Hellenthal, Nicholas J
15 A model for rural oncology.
by Heifetz, Laurence J
16 Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
by Chamie, Karim
17 Effects of a mushroom mycelium extract on the treatment of prostate cancer.
by deVere White, Ralph W
18 Cost-benefit and outcome analysis: effect of prostate biopsy undergrading.
by Cambio, Angelo J
19 MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status.
by Vinall, Ruth L
20 Complex functions of mutant p53 alleles from human prostate cancer.
by Shi, Xu-Bao